论文部分内容阅读
目的观察消栓肠溶胶囊治疗急性期脑梗死患者的临床效果。方法选取医院收治的急性期脑梗死患者100例,随机分为观察组和对照组,每组50例。对照组接受常规康复治疗,观察组在此基础上使用消栓肠溶胶囊治疗,观察2组治疗前、治疗14 d后NIHSS评分情况;观察治疗1个月后生活能力评价情况。结果治疗后,观察组总有效率为90.0%,高于对照组的76.0%(P<0.05);治疗14 d后,2组NIHSS评分均显著改善,且观察组NIHSS评分改善优于对照组(P<0.01)。治疗1个月后,观察组日常生活能力量表Barthal指数(BI)≥75分31例,占62.0%;对照组BI≥75分14例,占28.0%,2组比较差异显著有统计学意义(P<0.01)。结论消栓肠溶胶囊治疗急性期脑梗死可显著改善患者神经功能,提高患者生活质量,值得推广应用。
Objective To observe the clinical effect of Xiaoshuan enteric-coated capsules in patients with acute cerebral infarction. Methods A total of 100 acute cerebral infarction patients admitted to hospital were randomly divided into observation group and control group, 50 cases in each group. The control group received routine rehabilitation treatment. The observation group was treated with Xiaoshuan enteric-coated capsules on this basis. The NIHSS scores of the two groups before and 14 days after treatment were observed. The evaluation of viability after 1 month of treatment was observed. Results After treatment, the total effective rate in the observation group was 90.0%, which was significantly higher than that in the control group (76.0%, P <0.05). After 14 days of treatment, the NIHSS scores of the two groups were significantly improved, and NIHSS score of the observation group improved better than that of the control group P <0.01). After 1 month of treatment, Barthal index (BI) ≥75 points and 31 cases (62.0%) in the observation group and 14 cases (28.0%) in the control group with BI≥75 were significantly different between the two groups (P <0.01). Conclusion Xiao Shuan enteric-coated capsules in the treatment of acute cerebral infarction can significantly improve the patient’s neurological function and improve the quality of life of patients, it is worth promoting the application.